rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Rashmi Kumar

Director

Company insider

Files Form 4 as: Director, Myriad Genetics.

In numbers

Trades disclosed
11
Buys
0
Sells
2
Bought
$0
Sold
$344K
Companies
1
Companies where not an officer
1
First trade
17 Sep 2020
Last trade
8 Jun 2026
Last filed
9 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
MYGN Myriad GeneticsDirector · Diagnostics & Labs · last 8 Jun 20260 buys · 2 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
8 Jun 2026filed 9 Jun 2026MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Sold$67K15,000 at $4.46filing
8 Jun 2026filed 9 Jun 2026MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Sold$67K15,000 at $4.46filing
4 Jun 2026filed 5 Jun 2026MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—59,701 at $0.00filing
4 Jun 2026filed 5 Jun 2026MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—59,701 at $0.00filing
5 Jun 2025filed 6 Jun 2025MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—49,796 at $0.00filing
19 Aug 2024filed 20 Aug 2024MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Sold$210K7,500 at $28.01filing
6 Jun 2024filed 7 Jun 2024MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—15,695 at $0.00filing
1 Jun 2023filed 2 Jun 2023MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—15,151 at $0.00filing
2 Jun 2022filed 3 Jun 2022MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—17,275 at $0.00filing
3 Jun 2021filed 4 Jun 2021MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—12,848 at $0.00filing
17 Sep 2020filed 18 Sep 2020MYGN Myriad GeneticsDiagnostics & LabsSEC FORM 4 Code A—23,923 at $0.00filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Benjamin Richard WheelerChief Financial Officer · Chief Financial Officer at Myriad Genetics, filing Form 4 there in the last year
Vishal SikriEVP, Commercial · EVP, Commercial at Myriad Genetics, filing Form 4 there in the last year
Jennifer Lynne FoxChief Legal Officer · Chief Legal Officer at Myriad Genetics, filing Form 4 there in the last year
Brian J. DonnellyChief Commerical Officer · Chief Commerical Officer at Myriad Genetics, filing Form 4 there in the last year
Samraat S. RahaPresident and CEO · President and CEO at Myriad Genetics, filing Form 4 there in the last year